CHI Advisors as of March 31, 2022
Portfolio Holdings for CHI Advisors
CHI Advisors holds 22 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Prometheus Biosciences | 25.5 | $60M | 1.6M | 37.76 | |
| Repare Therapeutics Ord (RPTX) | 15.6 | $37M | 2.6M | 14.24 | |
| Cullinan Oncology (CGEM) | 12.3 | $29M | 2.8M | 10.47 | |
| Pliant Therapeutics (PLRX) | 7.9 | $19M | 2.7M | 7.01 | |
| Vectivbio Hldg Ord Shs | 6.2 | $15M | 3.1M | 4.71 | |
| 2seventy Bio Common Stock (TSVT) | 5.9 | $14M | 820k | 17.06 | |
| Omega Therapeutics Common Stock (OMGA) | 2.8 | $6.6M | 1.1M | 6.24 | |
| Larimar Therapeutics (LRMR) | 2.6 | $6.1M | 1.5M | 4.05 | |
| Freeline Therapeutics Hldgs Sponsored Ads | 2.3 | $5.4M | 4.9M | 1.12 | |
| Kezar Life Sciences | 2.2 | $5.2M | 315k | 16.62 | |
| Ikena Oncology (IKNA) | 2.1 | $5.0M | 815k | 6.10 | |
| Oncorus | 1.8 | $4.3M | 2.4M | 1.78 | |
| Akouos | 1.7 | $4.0M | 836k | 4.75 | |
| Compass Therapeutics (CMPX) | 1.6 | $3.9M | 2.8M | 1.37 | |
| Orchard Therapeutics Ads | 1.6 | $3.8M | 5.3M | 0.71 | |
| G1 Therapeutics | 1.6 | $3.7M | 489k | 7.60 | |
| Inozyme Pharma (INZY) | 1.6 | $3.6M | 892k | 4.09 | |
| Keros Therapeutics (KROS) | 1.4 | $3.4M | 62k | 54.38 | |
| Corvus Pharmaceuticals (CRVS) | 1.2 | $2.8M | 1.7M | 1.64 | |
| Ovid Therapeutics (OVID) | 1.1 | $2.7M | 853k | 3.14 | |
| Precision Biosciences Ord | 0.8 | $1.9M | 607k | 3.08 | |
| Spdr Ser Tr S&p Biotech Put Option (XBI) | 0.1 | $206k | 223k | 0.93 |
